We are live on ! Find out more
EEG

E.E. Geduld Portfolio holdings

AUM $178M
1-Year Est. Return 29.34%
This Fund
S&P 500
This Quarter Est. Return
-7.61%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$107M
AUM Growth
-$54.2M
Cap. Flow
-$24M
Cap. Flow %
-22.49%
Top 10 Hldgs %
54.93%
Holding
347
New
45
Increased
19
Reduced
60
Closed
132

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.59M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.36M
3
SIMO icon
Silicon Motion
SIMO
+$870K
4
AMZN icon
Amazon
AMZN
+$758K
5
LNKD
LinkedIn Corporation
LNKD
+$596K

Top Sells

Rank Stock Value
1
BLUE
bluebird bio
BLUE
+$1.75M
2
CSOD
Cornerstone OnDemand, Inc.
CSOD
+$957K
3
CPRI icon
Capri Holdings
CPRI
+$842K
4
SAGE
Sage Therapeutics
SAGE
+$803K
5
CY
Cypress Semiconductor
CY
+$764K

Sector Composition

Rank Sector Weight
1 Financials 45.84%
2 Miscellaneous 25.05%
3 Healthcare 9.93%
4 Consumer Discretionary 6.85%
5 Technology 4.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESPR
176
DELISTED
Esperion Therapeutics
ESPR
– –
-7,500
Closed -$613K
EXAS
177
DELISTED
Exact Sciences
EXAS
– –
-10,000
Closed -$297K
FOLD
178
DELISTED
Amicus Therapeutics
FOLD
– –
-25,000
Closed -$354K
LKFT
179
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
– –
-5,000
Closed -$258K
GOOG icon
180
CALL
Alphabet (Google) Class C
GOOG
$4.13T
– –
-70,000
Closed -$1.89M
GRBK icon
181
Green Brick Partners
GRBK
$3.13B
– –
-26,739
Closed -$293K
HES
182
DELISTED
Hess
HES
– –
-5,200
Closed -$348K
HIMX
183
CALL
Himax Technologies
HIMX
$2.45B
– –
-70,000
Closed -$562K
HIMX
184
Himax Technologies
HIMX
$2.45B
– –
-55,000
Closed -$442K
HOLX
185
DELISTED
Hologic
HOLX
– –
-10,000
Closed -$381K
INCY icon
186
Incyte
INCY
$25.9B
– –
-2,800
Closed -$292K
IRDM icon
187
Iridium Communications
IRDM
$5.05B
– –
-25,000
Closed -$227K
K
188
DELISTED
Kellanova
K
– –
-5,325
Closed -$314K
LOCO icon
189
CALL
El Pollo Loco
LOCO
$463M
– –
-20,000
Closed -$414K
LPCN icon
190
Lipocine
LPCN
$18.4M
– –
-1,176
Closed -$172K
LRCX icon
191
Lam Research
LRCX
$399B
– –
-35,000
Closed -$285K
LVS icon
192
Las Vegas Sands
LVS
$28.7B
– –
-5,000
Closed -$263K
MCD icon
193
CALL
McDonald's
MCD
$184B
– –
-30,000
Closed -$2.85M
MCRB icon
194
Seres Therapeutics
MCRB
$49.7M
– –
-250
Closed -$208K
META icon
195
CALL
Meta Platforms (Facebook)
META
$1.45T
– –
-20,000
Closed -$1.72M
MGM icon
196
MGM Resorts International
MGM
$10.8B
– –
-30,018
Closed -$548K
MRVL icon
197
CALL
Marvell Technology
MRVL
$217B
– –
-15,000
Closed -$198K
MU icon
198
CALL
Micron Technology
MU
$1.06T
– –
-10,000
Closed -$188K
NFBK
199
DELISTED
Northfield Bancorp
NFBK
– –
-10,000
Closed -$151K
OGEN icon
200
Oragenics
OGEN
$2.4M
– –
-1
Closed -$34K
6 7
8
9 10

Similar funds

BC
Bocage Capital San Francisco, California $185M AUM 61.49% 1-Year Est. Return
PFM
PacWest Financial Management Phoenix, Arizona $169M AUM 8.84% 1-Year Est. Return
SRP
Saddle Road Partners Omaha, Nebraska $197M AUM 13.19% 1-Year Est. Return
CF
CenterStar Fund Chicago, Illinois $159M AUM 13.43% 1-Year Est. Return
SA
Steadfast Advisors New York $204M AUM 28.42% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
SIG
Stanford Investment Group Mountain View, California $205M AUM 7.44% 1-Year Est. Return
VWM
Vector Wealth Management Minneapolis, Minnesota $142M AUM 10.42% 1-Year Est. Return

E.E. Geduld's Q3 2015 Portfolio in Review

As of Q3 2015, E.E. Geduld held 347 positions worth $107M, down 34% from $161M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

E.E. Geduld withdrew a net $24M in Q3 2015, closing 132 positions and reducing 60 holdings. Its most notable exit was bluebird bio, an estimated $1.75M position sold in full.

By sector, the portfolio is most concentrated in Financials at 46% of assets, up from 33% a quarter earlier, followed by Miscellaneous and Healthcare.

Against the trend, E.E. Geduld opened a new position in Bristol-Myers Squibb worth $1.48M.

  • E.E. Geduld's largest Q3 2015 buy was Bristol-Myers Squibb: 25,000 shares worth $1.48M.
  • E.E. Geduld added most to Amazon in Q3 2015, an estimated $758K increase.
  • E.E. Geduld's biggest Q3 2015 reduction was Ariad Pharmaceuticals Inc, cutting an estimated $578K.
  • E.E. Geduld fully exited bluebird bio in Q3 2015, selling an estimated $1.75M.
  • E.E. Geduld's ten largest holdings make up 55% of its $107M portfolio in Q3 2015.
  • E.E. Geduld opened 45 new positions and closed 132 in Q3 2015.
  • E.E. Geduld's portfolio value fell 34% quarter-over-quarter to $107M.

Based on E.E. Geduld's 13F filing for Q3 2015, filed 6 Nov 2015.